Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) (N-Term) Peptid
KCNIP3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle DREAM (KCNIP3) Produkte
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LLGDLGHTPL SKKEGIKWQR PRLSRQALMR CCLVKWILSS TAPQGSDSSD
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- KCNIP3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
- Hintergrund
-
This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins, which belong to the recoverin branch of the EF-hand superfamily. Members of this family are small calcium binding proteins containing EF-hand-like domains. They are integral subunit components of native Kv4 channel complexes that may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. The encoded protein also functions as a calcium-regulated transcriptional repressor, and interacts with presenilins. Alternatively spliced transcript variants encoding different isoforms have been described.
Alias Symbols: CSEN, DREAM, KCHIP3
Protein Size: 256 - Gen-ID
- 30818
- NCBI Accession
- NM_001034914, NP_001030086
- UniProt
- Q9Y2W7
-
Sie sind hier:
